Physician profile
Robert Wayne Besinger
NPI 1497042030
$581.63
in general payments reported to CMS, 2019-2025
17 companies · $58.42 in 2025
The $58.42 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $87.01 · 2023: $20.03 · 2024: $238 · 2025: $58.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $97.65 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $66.01 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $59.32 | 2024 | Voquezna |
| Novo Nordisk INC | $56.31 | 2024-2025 | Ozempic, Saxenda, Wegovy |
| Neos Therapeutics, LP | $48.74 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.60 | 2024 | |
| Sanofi Pasteur INC. | $30.21 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $29.49 | 2024 | Gemtesa |
| Glaxosmithkline, LLC. | $26.87 | 2019 | |
| Lilly USA, LLC | $21.62 | 2024 | Zepbound, Jardiance |
| Lundbeck LLC | $20.53 | 2024 | Vyepti |
| Boston Scientific Corporation | $16.67 | 2025 | Wavewriter Alpha Prime 16 |
| Takeda Pharmaceuticals U.S.A., INC. | $16.06 | 2020 | |
| Shire North American Group INC | $13.44 | 2019 | |
| Axsome Therapeutics, INC. | $13.26 | 2024 | Auvelity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.65 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Besinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.